Page 3 - Nasdaq Tech News Today

First Trust Direct Indexing L.P. lessened its stake in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 14.0% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,380 shares of the biotechnology company’s stock after selling 711 shares during the quarter. First Trust Direct […]

Kornitzer Capital Management Inc. KS raised its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 0.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 192,663 shares of the biotechnology company’s stock after buying an additional 630 shares during the quarter. […]

Bio-Techne (NASDAQ:TECH – Get Free Report) and Genfit (NASDAQ:GNFT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, analyst recommendations, institutional ownership, valuation, dividends and profitability. Analyst Ratings This is a summary of current ratings and […]

Shares of Bio-Techne Co. (NASDAQ:TECH – Get Free Report) have been given a consensus rating of “Moderate Buy” by the ten brokerages that are currently covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 1-year price […]

UBS Group initiated coverage on shares of Bio-Techne (NASDAQ:TECH – Free Report) in a report published on Thursday morning, MarketBeat Ratings reports. The firm issued a buy rating and a $80.00 price objective on the biotechnology company’s stock. A number of other equities research analysts have also recently weighed in on the stock. KeyCorp cut […]

Epoch Investment Partners Inc. lessened its holdings in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 4.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 31,704 shares of the biotechnology company’s stock after selling 1,591 shares during the quarter. Epoch Investment Partners Inc.’s […]

US Bancorp DE lessened its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 3.0% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 157,077 shares of the biotechnology company’s stock after selling 4,813 shares during the period. US Bancorp DE’s holdings […]

StockNews.com cut shares of Bio-Techne (NASDAQ:TECH – Free Report) from a buy rating to a hold rating in a research note published on Saturday morning. Other research analysts have also recently issued reports about the company. Royal Bank of Canada lowered their target price on Bio-Techne from $85.00 to $83.00 and set a sector perform […]

StockNews.com lowered shares of Bio-Techne (NASDAQ:TECH – Free Report) from a buy rating to a hold rating in a report published on Saturday. Several other brokerages also recently issued reports on TECH. Stephens reaffirmed an overweight rating and set a $100.00 price target on shares of Bio-Techne in a report on Wednesday, August 9th. TheStreet […]

Bio-Techne (NASDAQ:TECH – Free Report) had its target price cut by KeyCorp from $115.00 to $80.00 in a research note released on Wednesday, Benzinga reports. They currently have an overweight rating on the biotechnology company’s stock. KeyCorp also issued estimates for Bio-Techne’s Q3 2024 earnings at $0.43 EPS and Q4 2024 earnings at $0.47 EPS. […]